American Board of Obesity Medicine

01/07/2026

"I decided to pursue board certification in obesity medicine to help me deliver the highest quality care for patients. Once the OSA indication for zepbound was added, I could see the direct interaction of sleep medicine and obesity medicine. This field is going to be changing and growing rapidly. I want to be on the forefront of offering the most effective treatment options to my patients. This training is helping me do that." -- John Schwab MD, DABOM

12/29/2025

The NIH recently held a daylong symposium on research strategies for sustainable care featuring insight from numerous ABOM diplomates. If you missed all or part of the symposium, watch it here https://bit.ly/3YNpVPf

Highly effective anti-obesity medications (AOMs), including semaglutide and tirzepatide, can produce mean weight loss of greater than 15% and have shown effectiveness in the prevention or control of obesity-related comorbidities and complications, such as type 2 diabetes, major cardiovascular eve...

12/18/2025

Venkata Sushma Chamarthi, MD, DABOM of Valley Children's shares that achieving ABOM diplomate status has strengthened her ability to address complex metabolic issues, prescribe medication safely, and create care plans that truly help kids and families thrive.

12/18/2025

Learn more about the 2K physicians who just achieved first-time certification in : https://bit.ly/49df4nL

2,000 pass October 2025 ABOM exam-total number of obesity medicine docs tops 11K

12/17/2025

"Getting ABOM certification is the best way to acquire comprehensive knowledge to understand and treat obesity."

12/10/2025

"I believe that the solution to most medical issues lies in treating obesity. If we were less biased and more sympathetic as providers in addressing issues with weight maintenance early on, we could decrease the disease and deal with a healthy population. What a dream!"

12/08/2025

Results are in! Last week ABOM welcomed 2,000 new diplomates who passed the October obesity medicine certification exam. We wish these new diplomates good luck on the important journey of offering patients with obesity evidence-based, compassionate care. You are all DABOM!

12/03/2025

"I am working in a FQHC serving a population that is underinsured or uninsured in about 41% of the cases…Better understanding of this condition will provide me the tools needed to give a better service and education to our community."

12/03/2025

ABOM Diplomates Allison Rhodes MD, DABOM, FOMA and Peminda Cabandugama MD, DABOM talk to Medscape about -1 exit planning: https://wb.md/3MmbVJg

No matter why a patient decides to stop using the popular drugs, be ready to help them transition and stay healthy.

11/19/2025

"I was a family medicine doctor and a lot of my patients are struggling with obesity. I decided to take a year off and do the fellowship so I can help them."

11/12/2025

"I enjoy helping people along their weight loss journey. It gives great joy knowing that you are literally changing their lives for the better."

11/10/2025

Thanks to CNN for speaking to ABOM Diplomate and American Board of Obesity Medicine Foundation Chief Medical Officer Dr. Kimberly Gudzune for this article on obesity medication coverage: https://cnn.it/3JR8wkQ

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.